The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Neurotoxicity of Alzheimer’s disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
Open accessAbstract
The amyloid peptides Aβ(40) and Aβ(42) of Alzheimer's disease are thought to contribute differentially to the disease process. Although Aβ(42) seems more pathogenic than Aβ(40), the reason for this is not well understood. We show here that small alterations in the Aβ(42):Aβ(40) ratio dramatically affect the biophysical and biological properties of the Aβ mixtures reflected in their aggregation kinetics, the morphology of the resulting amyloid fibrils and synaptic function tested in vitro and in vivo. A minor increase in the Aβ(42):Aβ(40) ratio stabilizes toxic oligomeric species with intermediate conformations. The initial toxic impact of these Aβ species is synaptic in nature, but this can spread into the cells leading to neuronal cell death. The fact that the relative ratio of Aβ peptides is more crucial than the absolute amounts of peptides for the induction of neurotoxic conformations has important implications for anti-amyloid therapy. Our work also suggests the dynamic nature of the equilibrium between toxic and non-toxic intermediates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased Aβ 42:40 ratio in oligodendrocytes could contribute to the high proportion of soluble aggregates [28,42,43]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aβ40 is present in larger amounts in the brain, yet Aβ42 is more neurotoxic and has a higher tendency to aggregate.8–11”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the longer and more hydrophobic Aβ42 isoform has a higher tendency to generate neurotoxic oligomeric species.9,10”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although Aβ40 is present in larger amounts in the brain, Aβ42 was found to be more neurotoxic and have a higher tendency to aggregate.4,5”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Although it was shown in previous studies9,10,21 that the Aβ42 peptide is more prone to form neurotoxic soluble Aβ oligomers than the Aβ40 peptide”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“…potently disrupt synaptic plasticity (Klyubin et al, 2008; Shankar et al, 2008), an Ab species of 56 kDa has been found neurotoxic in Tg2576 mice (Lesne et al, 2006), lipid-induced oligomers from mature fibrils (Martins et al, 2008), ADDLs (Lambert et al, 1998; Gong et al, 2003; Lacor et al,…”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722
Flagged first, then by citations
1 of the 61 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 538
Peripheral Amyloid Levels Present Gender Differences Associated with Aging in AβPP/PS1 Mice
Ordóñez‐Gutiérrez, L., Antón, M., & Wandosell, F. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141158 · Cited by 45
Härd, T. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08295.x · Cited by 41
Rothman, S. M., Tanis, K. Q., Gandhi, P., Malkov, V. A., Marcus, J., Pearson, M. S., Stevens, R. C., Gilliland, J., Ware, C. M., Mahadomrongkul, V., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1265-7 · Cited by 41
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Atlante, A., Amadoro, G., Latina, V., & Valenti, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226742 · Cited by 40
Amyloid beta modulation of neuronal network activity in vitro
Charkhkar, H., Meyyappan, S., Matveeva, E. G., Moll, J. R., McHail, D. G., Peixoto, N., Cliff, R. O., & Pancrazio, J. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.09.036 · Cited by 39
Jiao, H., Shi, K., Zhang, W., Yang, L., Yang, L., Guan, F., & Yang, B. (2016) · Oncology Letters · doi:10.3892/ol.2016.4857 · Cited by 39
Adami, P. V. M., Galeano, P., Wallinger, M. L., Quijano, C., Rabossi, A., Pagano, E. S., Olivar, N., Toso, C. R., Cardinali, D. P., Brusco, L. I., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.014 · Cited by 39
Ratnayaka, J. A., Lynn, S. A., Keeling, E., Munday, R., Gabha, G., Griffiths, H., & Lotery, A. J. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.205083 · Cited by 41
Matrix Metalloproteinases, Neural Extracellular Matrix, and Central Nervous System Pathology
Luca, C. D., & Papa, M. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.04.002 · Cited by 39
Amyloid β Fibril Elongation by Monomers Involves Disorder at the Tip
Bacci, M., Vymětal, J., Mihajlovic, M., Caflisch, A., & Vitalis, A. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00662 · Cited by 39
Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
Baldassarre, M., Baronio, C. M., Morozova‐Roche, L. A., & Barth, A. (2017) · Chemical Science · doi:10.1039/c7sc01743j · Cited by 39
Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity
Ippati, S., Deng, Y., van der Hoven, J., Heu, C., van Hummel, A., Chua, S. W., Parić, E., Chan, G., Feiten, A., Fath, T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011876118 · Cited by 39
Mazzitelli, S., Filipello, F., Rasile, M., Lauranzano, E., Cucuzza, C. S., Tamborini, M., Pozzi, D., Barajon, I., Toni Giorgino, A., Natalello, A., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0381-9 · Cited by 38
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 39
Nguyen, P. H., Campanera, J. M., Ngô, S. T., Loquet, A., & Derreumaux, P. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b05288 · Cited by 38
Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation
Yang, T., Zhu, Z., Yin, E., Wang, Y., Zhang, C., Yuan, H., Zhang, H., Jin, S., Guo, Z., & Wang, X. (2019) · Chemical Science · doi:10.1039/c9sc03042e · Cited by 38
Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
Gámez, P., & Caballero, A. B. (2015) · AIP Advances · doi:10.1063/1.4921314 · Cited by 37
Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer’s Disease
Korsak, M., & Kozyreva, T. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20164-1_14 · Cited by 37
Pathophysiological function of ADAMTS enzymes on molecular mechanism of Alzheimer’s disease
Gurses, M. S., Ural, M. N., Gulec, M. A., Akyol, O., & Akyol, S. (2016) · Aging and disease · doi:10.14336/ad.2016.0111 · Cited by 35
Secreted endogenous macrosomes reduce Aβ burden and ameliorate Alzheimer’s disease
Wang, C., Yang, Y., Zhang, X., Shi, Z., Gao, H., Zhong, M., Fan, Y., Zhang, H., Liu, B., & Qing, G. (2023) · Science Advances · doi:10.1126/sciadv.ade0293 · Cited by 35
Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
Villar‐Piqué, A., Espargaró, A., Sabaté, R., de Groot, N. S., & Ventura, S. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-55 · Cited by 36
Kuzuya, A., Zoltowska, K. M., Post, K. L., Arimon, M., Li, X., Svirsky, S. E., Maesako, M., Muzikansky, A., Gautam, V., Kovacs, D. M., et al. (2016) · BMC Biology · doi:10.1186/s12915-016-0248-3 · Cited by 35
Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation
Windsor, P. K., Plassmeyer, S. P., Mattock, D. S., Bradfield, J. C., Choi, E. Y., Miller, B. R., & Han, B. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062888 · Cited by 35
Wang, F., Zhou, X., Yang, Q., Xu, W., Wang, F., Chen, Y., & Chen, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027649 · Cited by 35
Salgado-Puga, K., Rodríguez-Colorado, J., Prado-Alcalá, R. A., & Peña‐Ortega, F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160543 · Cited by 35
Lim, J. L., Lin, C., Huang, C., & Chang, L. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113676 · Cited by 34
Schultz, S. A., Liu, L., Schultz, A. P., Fitzpatrick, C. D., Levin, R., Bellier, J., Shirzadi, Z., Joseph‐Mathurin, N., Chen, C. D., Benzinger, T. L. S., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00236-9 · Cited by 35
Liu, J., Liu, S., Matsumoto, Y., Murakami, S., Sugakawa, Y., Kami, A., Tanabe, C., Maeda, T., Michikawa, M., Komano, H., et al. (2015) · Scientific Reports · doi:10.1038/srep12059 · Cited by 35
Sun, Y., Islam, S., Michikawa, M., & Zou, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031757 · Cited by 33
Single-Molecule Imaging Reveals Aβ42:Aβ40 Ratio-Dependent Oligomer Growth on Neuronal Processes
Johnson, R. D., Schauerte, J. A., Chang, C.-C., Wisser, K. C., Althaus, J. C., Carruthers, C. J. L., Sutton, M. A., Steel, D. G., & Gafni, A. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.12.051 · Cited by 34
Dehury, B., Tang, N., Mehra, R., Blundell, T. L., & Kepp, K. P. (2020) · RSC Advances · doi:10.1039/d0ra04683c · Cited by 33
Perdigão, C., Barata, M. A., Burrinha, T., & Almeida, C. G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101056 · Cited by 33
Hexafluoroisopropanol induces self‐assembly of β‐amyloid peptides into highly ordered nanostructures
Pachahara, S. K., Chaudhary, N., Subbalakshmi, C., & Nagaraj, R. (2012) · Journal of Peptide Science · doi:10.1002/psc.2391 · Cited by 33
Role of F3/contactin expression profile in synaptic plasticity and memory in aged mice
Puzzo, D., Bizzoca, A., Loreto, C., Guida, C. A., Gulisano, W., Frasca, G., Bellomo, M., Castorina, S., Gennarini, G., & Palmeri, A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.004 · Cited by 35
Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease
Wesson, D. W., Nixon, R. A., Levy, E., & Wilson, D. A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8177-1 · Cited by 34
Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
Bagyinszky, E., Youn, Y. C., An, S. S. A., & Kim, S. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s116218 · Cited by 33
Takeda, K., Uda, A., Mitsubori, M., Nagashima, S., Iwasaki, H., Ito, N., Shiiba, I., Ishido, S., Matsuoka, M., Inatome, R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01720-2 · Cited by 32
Das, S. S., Gopal, P. M., Thomas, J. V., Mohan, M. C., Thomas, S. C., Maliakel, B. P., Krishnakumar, I. M., & Chakrapani, P. S. B. (2023) · Frontiers in Dementia · doi:10.3389/frdem.2023.1222708 · Cited by 35
Amyloids: The History of Toxicity and Functionality
Yakupova, E. I., Bobyleva, L. G., Shumeyko, S. A., Vikhlyantsev, I. M., & Bobylev, A. G. (2021) · Biology · doi:10.3390/biology10050394 · Cited by 34
Natural Amyloid-Beta Oligomers Acutely Impair the Formation of a Contextual Fear Memory in Mice
Kittelberger, K. A., Piazza, F., Tesco, G., & Reijmers, L. G. J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029940 · Cited by 35
Carreras, I., McKee, A. C., Choi, J., Aytan, N., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.025 · Cited by 35
Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer’s Disease Pathogenesis
Zoltowska, K. M., & Berezovska, O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0487-5 · Cited by 32
Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
Toyn, J. H., & Ahlijanian, M. K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt244 · Cited by 31
Dashinimaev, E. B., Artyuhov, A., Bolshakov, A. P., Vorotelyak, E. A., & Vasiliev, A. V. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160945 · Cited by 32
Induction of Amyloid-β 42 Production by Fipronil and Other Pyrazole Insecticides
Cam, M., Durieu, É., Bodin, M., Manousopoulou, A., Koslowski, S., Vasylieva, N., Barnych, B. B., Hammock, B. D., Bohl, B., Koch, P., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170875 · Cited by 31
Current anti-Alzheimer’s disease effect of natural products and their principal targets
Zhu, Y., Peng, L., Hu, J., Chen, Y., & Chen, F. (2019) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2019.03.1105 · Cited by 31
Fujita, Y., Kano, K., Kishino, S., Nagao, T., Shen, X., Sato, C., Hatakeyama, H., Ota, Y., Niibori, S., Nomura, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88870-9 · Cited by 31
A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation
Zhang, X., Zhang, X., Zhong, M., Zhao, P., Guo, C., Li, Y., Xu, H. J., Wang, T., & Gao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136842 · Cited by 30
de Almeida, N. E. C., Do, T. D., Jhatro, M., LaPointe, N. E., Feinstein, S. C., Shea, J., & Bowers, M. T. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00280 · Cited by 30
Johnson, R. D., Steel, D. G., & Gafni, A. (2014) · Protein Science · doi:10.1002/pro.2479 · Cited by 29
Interactions of amyloid-β peptides on lipid bilayer studied by single molecule imaging and tracking
Chang, C., Edwald, E., Veatch, S. L., Steel, D. G., & Gafni, A. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.017 · Cited by 31
Zhang, X., Zhang, X., Li, Y., Zhong, M., Zhao, P., Guo, C., Xu, H. J., Wang, T., & Gao, H. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00035 · Cited by 29
Scherberich, J. E., Kellermeyer, M., Ried, C., & Hartinger, A. (2005) · PubMed · Cited by 29
Xing, H., Lim, Y.-A., Chong, J. R., Lee, J. H., Aarsland, D., Ballard, C. G., Francis, P. T., Chen, C., & Lai, M. K. P. (2016) · Molecular Brain · doi:10.1186/s13041-016-0264-9 · Cited by 29
β-sheet propensity controls the kinetic pathways and morphologies of seeded peptide aggregation
Morriss-Andrews, A., Bellesia, G., & Shea, J. (2012) · The Journal of Chemical Physics · doi:10.1063/1.4755748 · Cited by 28
Yang, X., Zou, L., Wang, K., Ye, X.-L., & Huang, T. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262593 · Cited by 28
Menezes, R., Martins, I. C., Ferreira, S., & Raimundo, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.300323 · Cited by 29
Self-citationChang, C.-C., Althaus, J. C., Carruthers, C. J. L., Sutton, M. A., Steel, D. G., & Gafni, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082139 · Cited by 28
Aβ42 oligomers modulate β-secretase through an XBP-1s-dependent pathway involving HRD1
Gerakis, Y., Dunys, J., Bauer, C., & Checler, F. (2016) · Scientific Reports · doi:10.1038/srep37436 · Cited by 30
U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease
Bai, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00075 · Cited by 28
Zhang, X., Zhong, M., Zhao, P., Zhang, X., Li, Y., Wang, X., Sun, J., Wang, L., Sun, H., Wang, Z., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00676a · Cited by 27
Kilinc, D., Vreulx, A.-C., Mendes, T., Flaig, A., Coelho, D. M., Verschoore, M., Demiautte, F., Amouyel, P., Bank, N.-C. B., Eysert, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa139 · Cited by 34
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Barrera-Ocampo, A. A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.034 · Cited by 30
Peptide-surfactant interactions: consequences for the amyloid-beta structure.
Rocha, S., Loureiro, J., Brezesinski, G., & Pereira, M. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2012.02.129 · Cited by 27
Superhydrophobic Surfaces Boost Fibril Self-Assembly of Amyloid β Peptides
Accardo, A., Shalabaeva, V., Cola, E. D., Burghammer, M. C., Krahne, R., Riekel, C., & Dante, S. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b06219 · Cited by 27
Kang, S., Ha, S., Park, H., Nam, E., Suh, W. H., Suh, Y., & Chang, K. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00273 · Cited by 27
The chelation targeting metal–Aβ40 aggregates may lead to formation of Aβ40 oligomers
Zhang, Y., Chen, L.-Y., Yin, W.-X., Yin, J., Zhang, S.-B., & Liu, C.-L. (2011) · Dalton Transactions · doi:10.1039/c1dt00020a · Cited by 26
Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles
Penke, B., Tóth, A. M., Földi, I., Szűcs, M., & Janáky, T. (2012) · Electrophoresis · doi:10.1002/elps.201200297 · Cited by 26
Toyn, J. H., Boy, K. M., Raybon, J. J., Meredith, J. E., Robertson, A. S., Guss, V. L., Hoque, N., Sweeney, F., Zhuo, X., Clarke, W., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232249 · Cited by 26
Vicidomini, C., Cioffi, F., Broersen, K., Roviello, V., Riccardi, C., Montesarchio, D., Capasso, D., Gaetano, S. D., Musumeci, D., & Roviello, G. N. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0473 · Cited by 26
Self-citationChua, X. Y., Chong, J. R., Cheng, A. L., Lee, J. H., Ballard, C. G., Aarsland, D., Francis, P. T., & Lai, M. K. P. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105251 · Cited by 26
Cuccioloni, M., Cecarini, V., Bonfili, L., Pettinari, R., Tombesi, A., Pagliaricci, N., Petetta, L., Angeletti, M., & Eleuteri, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158710 · Cited by 27
Surówka, A. D., Pilling, M. J., Henderson, A., Boutin, H., Christie, L., Szczerbowska‐Boruchowska, M., & Gardner, P. (2016) · The Analyst · doi:10.1039/c6an01797e · Cited by 26
Small‐molecule inducers of Aβ‐42 peptide production share a common mechanism of action
Bettayeb, K., Oumata, N., Zhang, Y., Luo, W., Bustos, V., Galons, H., Greengard, P., Meijer, L., & Flajolet, M. (2012) · The FASEB Journal · doi:10.1096/fj.12-212985 · Cited by 28
Sandberg, A., Berenjeno‐Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01141-1 · Cited by 29
Vicente, M. C., Addo-Osafo, K., & Vossel, K. A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1277613 · Cited by 25
Manso, Y., Carrasco, J., Comes, G., Adlard, P. A., Bush, A. I., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1045-y · Cited by 30
Ştefănescu, R., Stanciu, G. D., Luca, A., Caba, I.-C., Tamba, B.-I., & Mihai, C. T. (2019) · Molecules · doi:10.3390/molecules24061167 · Cited by 25
Zhang, Z., Han, K., Wang, C., Sun, C., & Jia, N. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00046 · Cited by 24
Disorder at the Tips of a Disease-Relevant Aβ42 Amyloid Fibril: A Molecular Dynamics Study
Ilie, I. M., & Caflisch, A. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b05236 · Cited by 24
A Review of the Familial Alzheimer’s Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1
Jiang, H., Jayadev, S., Lardelli, M. T., & Newman, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180656 · Cited by 25
Protective ApoE variants support neuronal function by effluxing oxidized phospholipids
Ralhan, I., Do, A. D., Bae, J.-Y., Feringa, F. M., Cai, W., Chang, J., Chik, K., Lee, N. Y. J., Gerry, C. J., van der Kant, R., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.10.040 · Cited by 23
Zinc utilization by microglia in Alzheimer’s disease
Shippy, D. C., Oliai, S. F., & Ulland, T. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107306 · Cited by 25
Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations
Mani, S., Swargiary, G., Singh, M., Agarwal, S., Dey, A., Ojha, S. K., & Jha, N. K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119985 · Cited by 24
Yoshida, N., Kato, Y., Takatsu, H., & Fukui, K. (2022) · Biomedicines · doi:10.3390/biomedicines10020281 · Cited by 23
Nagarajan, S., & Lapidus, L. J. (2017) · ChemBioChem · doi:10.1002/cbic.201700387 · Cited by 24
Hochard, A., Oumata, N., Bettayeb, K., Gloulou, O., Fant, X., Durieu, É., Buron, N., Porceddu, M., Borgne‐Sanchez, A., Galons, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121777 · Cited by 27
Cell size effects in the molecular dynamics of the intrinsically disordered Aβ peptide
Mehra, R., & Kepp, K. P. (2019) · The Journal of Chemical Physics · doi:10.1063/1.5115085 · Cited by 22
Edaravone Attenuates Aβ 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells
Guo, S., Qi, L., Guo, H., Yang, Q., Xue, Y., & Chen, R. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03782-y · Cited by 22
Li, X., Yang, Z., Chen, Y., Zhang, S., Wei, G., & Zhang, L. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01078 · Cited by 22
Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease
Merchant, J. P., Zhu, K., Henrion, M., Zaidi, S. S. A., Lau, B., Moein, S., Alamprese, M. L., Pearse, R. V., Bennett, D. A., Ertekin‐Taner, N., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04791-5 · Cited by 23
Cheung, S., Zhong, Y., Wu, L., Jia, X., He, M., Ai, Y., Jiao, Q., & Liang, Q. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117976 · Cited by 22
Globular and Protofibrillar Aβ Aggregates Impair Neurotransmission by Different Mechanisms
Moreth, J., Kroker, K. S., Schwanzar, D., Schnack, C., Arnim, C. A. F. V., Hengerer, B., Rosenbrock, H., & Kußmaul, L. (2013) · Biochemistry · doi:10.1021/bi3016444 · Cited by 24
Interrelationship between Changes in the Amyloid β 42/40 Ratio and Presenilin 1 Conformation
Zoltowska, K. M., Maesako, M., & Berezovska, O. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00127 · Cited by 23
Novel approaches to increase synaptic resilience as potential treatments for Alzheimer’s disease
Pham, A. Q., & Dore, K. (2023) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2022.03.032 · Cited by 21
Buchholz, S., Kabbani, M. A. A., Bell‐Simons, M., Kluge, L., Cagmak, C., Klimek, J., Haag, N., Iohan, L. D. C. C., Coulon, A., Costa, M. R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14403 · Cited by 21
Simvastatin Treatment Preserves Synaptic Plasticity in AβPPswe/PS1dE9 Mice
Métais, C., Brennan, K., Mably, A. J., Scott, M., Walsh, D. M., & Herron, C. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130257 · Cited by 25
SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1
Kurkinen, K. M. A., Marttinen, M., Turner, L. J., Natunen, T., Mäkinen, P. M., Haapalinna, F., Sarajärvi, T., Gabbouj, S., Kurki, M., Paananen, J., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.185215 · Cited by 21
Gray, A. L. H., Antevska, A., Link, B. A., Bogin, B. A., Burke, S. J., Dupuy, S. D., Collier, J. J., Levine, Z. A., Karlstad, M. D., & Do, T. D. (2021) · Chemical Science · doi:10.1039/d1sc01167g · Cited by 20
Meng, F., Kim, J.-Y., Louis, J. M., & Chung, H. S. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c06372 · Cited by 20
Metadata
- Authors
- Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., Braeken, D., Callewaert, G., Bartic, C., D'Hooge, R., Martins, I. C., Rousseau, F., Schymkowitz, J., & De Strooper, B.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Vrije Universiteit Brussel (BE)
- Rega Institute for Medical Research (BE)
- University of Twente (NL)
- IMEC (BE)
- Corresponding author
- Schymkowitz, Joost
- ORCID
- Venue
- The EMBO Journal
- Published
- 2010-09-03
- Volume
- 29
- Issue
- 19
- Pages
- 3408-3420
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC2957213
- OpenAlex
- W1966694507
- Cited by
- 532
- References
- 61
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 36 · 2023: 39 · 2022: 27 · 2021: 39 · 2020: 32 · 2019: 33 · 2018: 31 · 2017: 35 · 2016: 48 · 2015: 31 · 2014: 30 · 2013: 42 · 2012: 43
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- University of Twente Research Information (publishedVersion, other-oa)
- Lirias (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- University of Twente Research Information (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission (200611)
- Fonds Wetenschappelijk Onderzoek (P6/43)
- Vlaamse regering
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, Aβ42/Aβ40 ratio, neurotoxicity, oligomeric intermediates, fibril morphology, synaptic dysfunction, neuronal cell death, anti-amyloid therapy, peptide mixtures
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Biophysics, Fluorescent Dyes, Humans, Kinetics, Microelectrodes, Neurons, Peptide Fragments, Protein Binding, Thiazoles, Amyloid beta-Peptides, Spectroscopy, Fourier Transform Infrared, Patch-Clamp Techniques, Microscopy, Electron, Transmission, Mice, Benzothiazoles, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
